短期循环支援装置市场：市场规模（按细分市场）、份额、监管、报销、程序、预测（~2033 年）

冠状动脉疾病（CVD）是全世界过早死亡的主要原因。这包括中风、心臟病和其他心血管感染和疾病。根据世界卫生组织 (WHO) 显示，2016 年，CVD 导致全球 1,790 万人死亡。这些死亡人数占全球死亡人数的三分之一以上。

短期体外心室辅助装置主要用于在冠状动脉绕道手术 (CABG) 等开放性手术期间辅助心臟。随着此类手术变得不那么流行（被 PCI 取代），短期心室辅助装置的使用也在减少，因为医生更喜欢使用 IABP 导管和 PVAD 等侵入性较小的方法。

该报告深入探讨了全球短期循环支援设备市场，包括竞争格局、SWOT 分析、到 2033 年的市场预测、COVID-19 的影响以及区域和国家趋势。

目录

目前市面上的短期循环支援装置及竞争状况

• 洞察关键产业趋势
• 2015年至2033年短期循环支援装置各细分市场的市场总收入及市场前景
• 按细分市场划分的程序总数、单位数、平均售价和市场价值的详细数据

全球、区域和国家见解

• 短期循环支援装置市场SWOT分析
• 短期循环支援设备市场的竞争动态洞察与趋势
• 按国家/地区划分的医疗保健系统概览
• 各国报销政策
• 各国医疗技术法规现状

Abstract

Short Term Circulatory Support Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Short Term Circulatory Support Devices market for the year 2020 and beyond. CVDs are the main and leading cause for early death in the world. This incorporates stroke, heart attack, and other circulatory infections and diseases. As indicated by the World Health Organization (WHO), 17.9 million deaths occurred in 2016 around the world due to CVDs. These deaths accounted for over one third of all deaths worldwide.

Short-Term External/Paracorporeal Ventricular Assist Devices (Short-Term ExVADs) are primarily used to assist the heart during open surgery procedures, such as Coronary Artery Bypass Grafting (CABG). Since the popularity of this type of procedure is declining (and being replaced by PCI), the usage of Short-Term ExVADs is also declining as physicians prefer the minimally-invasive approaches of IABP Catheters and PVADs.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Short Term Circulatory Support Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Short Term Circulatory Support Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Short Term Circulatory Support Devices market.
• Competitive dynamics insights and trends provided for Short Term Circulatory Support Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abiomed Inc, LivaNova Plc, Getinge AB, Abbott Laboratories, Teleflex Inc, Zeon Medical Inc, Senko Medical Instrument Manufacturing Co Ltd, Berlin Heart GmbH, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Short Term Circulatory Support Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Short Term Circulatory Support Devices market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Short Term Circulatory Support Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Short Term Circulatory Support Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Short Term Circulatory Support Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable